Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Il y a 35 min

Agilent unveils combination real-time cell imager and analyzer following ACEA acquisition

Il y a 3 jours
Agilent Technologies has launched a new analyzer for research work that allows scientists to observe cell behavior and movement in real time while also collecting detailed biosensor information....
www.fiercebiotech.com
Bandeau FranceBiotechnologies
Une actualité de FierceBiotech a été ajouté(e)
Il y a 5 jours

Boehringer, MD Anderson build out 'virtual R&D center' for cancer research

Il y a 6 jours
German pharma Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have joined forces to create a new “virtual” R&D hub so the pair can work on cancer drugs....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 5 jours

Manufacturing Delays Set Back Autolus’ CAR-T Programs by Five Months

Il y a 1 semaine
The UK biotech Autolus’ shares have slumped as construction delays from a new manufacturing site have pushed back its CAR-T cell immunotherapy programs. Autolus is developing treatments for blood...
labiotech.eu
Une actualité de L'Usine Nouvelle a été ajouté(e)
Il y a 5 jours

Des scientifiques créent une structure minérale, très proche du tissu osseux

Il y a 6 jours
Le 6 août 2019, des chercheurs de l'Oregon Health and Science University ont annoncé avoir réussi à créer une structure très proche du... - L'Usine Santé
www.usinenouvelle.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 5 jours

Xontogeny's Landos Biopharma reels in $60M to ramp up IBD program

Il y a 6 jours
Landos Biopharma was the first biotech to come out of Xontogeny, the accelerator started by former Sarepta chief Chris Garabedian. Now, the company has picked up $60 million to propel its lead program...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 5 jours

Novartis sells phase 3 rare disease drug to Pharming

Il y a 6 jours
Pharming has licensed late-phase rare genetic disease treatment leniolisib from Novartis for $20 million (€17.9 million) upfront. The immunomodulator could come to market in activated PI3K-delta...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 5 jours

10 Biotech Books Recommended by Labiotech Readers

Il y a 6 jours
To help you enjoy the summer, here is a list of book suggestions for you to take with you on your travels, as recommended by our readers. We asked the Labiotech team what they liked to read last...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 5 jours

Deciphera soars as phase 3 cancer data tee up FDA filing

Il y a 6 jours
A phase 3 trial of Deciphera’s ripretinib in gastrointestinal stromal tumors has hit its primary endpoint. The data sparked a surge in the company's stock price, even though details of the...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 5 jours

AskBio Acquires Scottish Biotech to Make Gene Therapies More Precise

Il y a 6 jours
The US company AskBio has acquired the Edinburgh-based Synpromics to pool their gene therapy technologies and produce inducible gene therapies that target particular organs or cells. AskBio...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 5 jours

Datavant, PCORnet to build real-world data network spanning 60M patients

Il y a 6 jours
The People-Centered Research Foundation tapped Datavant to help it de-identify and coordinate the sharing of data across its national clinical research network covering over 60 million patients....
www.fiercebiotech.com
Charger plus d'actualités